BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3764554)

  • 1. [Role of circulating immune complexes in patients with erysipelas].
    Frolov VM; Rychnev VE; Frolov AF; Bala MA
    Sov Med; 1986; (7):114-6. PubMed ID: 3764554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of circulating immune complexes in patients with erysipelas].
    Frolov VM; Bala MA; Frolov AF; Rychnev VE
    Vrach Delo; 1985 Jun; (6):102-5. PubMed ID: 3161244
    [No Abstract]   [Full Text] [Related]  

  • 3. [Circulating immune complexes in patients with erysipelas].
    Il'inskiĭ IuA; Druganina AA; Pogorel'skaia LV; Podgorodnichenko VK; Lisenkov AN
    Sov Med; 1986; (9):20-3. PubMed ID: 3798215
    [No Abstract]   [Full Text] [Related]  

  • 4. [The circulating immune complexes in erysipelas: diagnostic and prognostic significance].
    Frolov VM; Rychnev VE; Bala MA
    Lab Delo; 1986; (3):159-61. PubMed ID: 2421086
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM; Boĭchenko PK; Peresadin NA
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Uptake" immunoenzyme analysis for the determination of unscreened antigenic determinants of Streptococcus pyogenes group-specific A polysaccharide within the circulating immune complexes of erysipelas patients].
    Shikhman AR; Anokhina GI; Cherkasov VL; Briko NI
    Lab Delo; 1988; (4):64-6. PubMed ID: 2457748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indicators of nonspecific resistance of the body in patients with erysipelas].
    Lipkovskaiia IV; Ermolin GA; Sokol AS; Pavlishin VV; Efremov AN
    Vrach Delo; 1989 Feb; (2):107-9. PubMed ID: 2711647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Free and bound antigen of Streptococcus group A L forms and the circulating immune complex level of erysipelas patients].
    Gorina LG; Kagan GIa; Gavrilova GA; Goncharova SA; Cherkasov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):106-9. PubMed ID: 6195846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistence of the L forms of hemolytic Streptococcus group A in patients with recurrent erysipelas].
    Gavrilova GA; Gorina LG; Goncharova SA; Cherkasov VL
    Vestn Akad Med Nauk SSSR; 1985; (3):13-7. PubMed ID: 3887793
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of autoimmune reactions in the treatment of erysipelas].
    Frolov VM; Peresadin NA; Baskakov IN; Trofimenko AN; Starik AD
    Vrach Delo; 1988 Sep; (9):107-10. PubMed ID: 3212978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation].
    Elagina LV; Savchenko TV; Pavlova MV
    Klin Med (Mosk); 1998; 76(1):25-7. PubMed ID: 9532910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The information value of immunological tests in predicting recurrences of erysipelas].
    Bala MA; Rychnev VE; Tret'iakova NV
    Vrach Delo; 1990 Jun; (6):118-20. PubMed ID: 2399705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Circulating immune complexes in the pathogenesis of recurrent erysipelas].
    Frolov AF; Rychnev VE; Frolov VM; Bala MA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):93-6. PubMed ID: 2936048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of detecting discrete antigens of group A Streptococcus and their antibodies in the blood of erysipelas patients].
    Cherkasov VL; Anokhina GI; Shikhman AR; Briko NI
    Klin Med (Mosk); 1995; 73(4):97-8. PubMed ID: 7474846
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circulating immune complexes in patients with acute myocardial infarct].
    Shustval' NF; Kinoshenko KIu
    Vrach Delo; 1986 Oct; (10):96-100. PubMed ID: 3798901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of serum antibodies in patients with recurrent erysipelas].
    Frolov VM; Rychnev VE; Zhuravleva NV
    Klin Med (Mosk); 1985 May; 63(5):91-5. PubMed ID: 4046519
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating immune complexes in limited forms of pulmonary tuberculosis].
    Gerasimova EV
    Probl Tuberk; 1984 Sep; (9):51-5. PubMed ID: 6504885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulating immune complexes and neutrophil function in syphilis].
    Glavinskaia TA; Rezaĭkina AV; Pavlovskaia VE; Frigo NV
    Vestn Dermatol Venerol; 1984 Jul; (7):27-30. PubMed ID: 6475273
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes in carcinoma of the pancreas.
    Mihas AA; Volanakis JE; Schrohenloher RE; Mihas TA
    Anticancer Res; 1981; 1(3):155-8. PubMed ID: 7342854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.